4 recruiting, 2 not yet recruiting, 1 active not recruiting, 1 completed. 8 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 4, Not yet recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 3 | 3 | Not yet recruiting 2, Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Medrol Veriderm: new trials by email Literature Review of Medrol Veriderm trials Research Report on Medrol Veriderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 153 | 2025-06-05 | 2026-10-27 |
| Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Cyclophosphamide, Cytarabine, Dexamethasone - Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2020-05-29 | 2026-09-14 |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors Methylprednisolone, Prednisone, Quality-of-Life Assessment - Cranial Nerve Disorder, Head and Neck Carcinoma | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 35 | 2019-10-16 | 2026-06-26 |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome Anti-Thymocyte Globulin, Cyclosporine, Filgrastim - Aplastic Anemia, de Novo Myelodysplastic Syndrome | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 140 | 2012-06-25 | 2026-06-22 |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 97 | 2009-09-01 | 2026-10-22 |
| Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Asparaginase, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 63 | 2008-07-14 | 2020-04-13 |
Burkitt Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Aplastic (1) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Cranial Nerve Diseases (1) · Leukemia, Biphenotypic, Acute (1) · Lymphoma (1) · Myelodysplastic Syndromes (1) · Oropharyngeal Neoplasms (1) · Prostatic Neoplasms (1)
M.D. Anderson Cancer Center (3) · National Cancer Institute (NCI) (3) · Children's Oncology Group (1) · ECOG-ACRIN Cancer Research Group (1)
United States (6) · Puerto Rico (2) · Australia (1) · Canada (1) · New Zealand (1)
Erin H Breese (1) · Farhad Ravandi-Kashani (1) · Katherine A Hutcheson, BA,MS,PHD (1) · Keith J August (1) · Michael Schweizer (1) · Naveen Pemmaraju (1) · Tapan M Kadia (1) · William B Slayton (1)
PMID 29618479, PMID 29812996, PMID 33242441
U10CA180886 (2), P30CA016672 (1), U10CA032102 (1), U10CA098543 (1), U10CA180820 (1), U10CA180888 (1)